Get started
Author

A Colón Lopez de Dicastillo

Observed names: A Colon Lopez De Dicastillo, A Colón López de Dicastillo, A. Colón López de Dicastillo, A. Colón-López de Dicastillo, A. Colόn Lόpez de Dicastillo, ANA COLÓN LÓPEZ DE DICASTILLO, Aitor Dicastillo, Ana Colon Lopez De Dicastillo, Ana Colón-López de Dicastillo
ORCID: 0000-0002-2434-3476
Observed ORCIDs: 0000-0002-2434-3476, 0009-0002-3076-686X
OpenAlex ID: A5064618572
5PSQ-029 Effectiveness and safety of evolocumab in real clinical practice
2019 · MV Villacañas Palomares, A Colón Lopez de Dicastillo, et al. · European Journal of Hospital Pharmacy · 2
PDF
Erenumab and Galcanezumab for Chronic Migraine Refractory to OnabotulinumtoxinA: A Real-World Comparative Study
2026 · Sara Martín-Yeves, Ana Colón-López de Dicastillo, et al. · Annals of Pharmacotherapy · 1
An updated review of the economic burden of multiple sclerosis: direct and indirect costs
2026 · Paloma Lanza-Leon, David Cantarero-Prieto, et al. · Frontiers in Immunology · 1
PDF
Comment on: Development and Implementation of a Pharmacist‐Led Aspirin Deprescribing Algorithm in Older Adults
2025 · Aitor Dicastillo, María Pérez de Albéniz Mateo, et al. · Journal of the American Geriatrics Society
PDF
Toxicidad De Siponimod Guiada Por Genotipo
2025 · VÍCTOR FERNÁNDEZ MARTÍNEZ, JULIA SÁNCHEZ GUNDIN, et al. · Sociedad Española de Farmacia Hospitalaria eBooks
20308. Análisis De Calidad De Vida Y Satisfacción Con El Tratamiento En Pacientes Tratados Con Natalizumab En Pauta Extendida
2024 · Y. Jiménez López, R. Rodríguez Herrero, et al. · Neurology Perspectives
Ab1349 Biologic and Targeted Synthetic Drugs Management in Rheumatoid Arthritis After Implementation of a Community Optimization Protocol
2024 · E. Aurrecoechea, J.L. Martín-Varillas, et al. · Annals of the Rheumatic Diseases
5PSQ-102 Ambulatory subcutaneous biologic therapy optimisation in rheumatology: implementation over time
2020 · S Lorenzo Martin, MV Villacañas Palomares, et al. · European Journal of Hospital Pharmacy
PDF
5PSQ-048 Real-world safety and tolerability of the recently commercialised palbociclib
2019 · A Colón López de Dicastillo, I Gutiérrez Pérez, et al. · European Journal of Hospital Pharmacy
PDF
DI-085 Evolution of antiretroviral prescriptions in treatment-naÏve HIV-infected patients
2015 · E Martínez de Ilarduya Bolado, M Gómez Martínez, et al. · European Journal of Hospital Pharmacy
CP-084 Use of infliximab for steroid-refractory graft-versus-host disease
2015 · L Senra Afonso, A Colón López de Dicastillo, et al. · European Journal of Hospital Pharmacy
SAT0590-HPR Economic Evaluation of Biological Therapies in Rheumatic Diseases
2014 · D. Gόmez Gόmez, A. Colόn Lόpez de Dicastillo, et al. · Annals of the Rheumatic Diseases
CP-041 Evaluation of the use of ustekinumab in clinical practice and its economic impact
2014 · A Colón López de Dicastillo, D Gómez Gómez, et al. · European Journal of Hospital Pharmacy
CP-069 Economic impact of biological treatments in rheumatic diseases: Abstract CP-069 Table 1
2014 · D Gómez Gómez, A Colón López de Dicastillo, et al. · European Journal of Hospital Pharmacy
PS-032 Antiretroviral drug prescribing errors in hospitalised patients
2014 · A Gomez Esteban, C Abraira Meriel, et al. · European Journal of Hospital Pharmacy
CP-001 Antibiotic strategy after the empirical phase in hospitalised pacients with positive blood cultures
2014 · C Abraira Meriel, LR López Giménez, et al. · European Journal of Hospital Pharmacy
CP-094 Discontinuation of enzyme replacement treatment with imiglucerase
2014 · LR López Giménez, A Gómez Esteban, et al. · European Journal of Hospital Pharmacy
Works count: 17
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type